CLINICAL TRIALS:
Consents
CTU Newsletter 2/2009
Click trial to get more information
Longitudinal Study of Ocular Complications of AIDS :LSOCA
Immunogenicity & Safety of a Quadrivalent HPV Vaccine in HIV-1-Infected Females: A5240
The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen: A5241
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX in HIV-1-Infected Adults on Potent Combination ART with Conserved Immune Function: A5247
A Phase III Comparative Study of Three Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers: A5257
An Open Label Trial of Mecasermin For HIV Associated Metabolic Disease: Mecasermin
A Phase 1b Partially Randomized Pilot Study Intended to Evaluate the Safety and Immunological Effects of HIV-1DNA Immunization (PennVax-B) With or Without Co-administration of constructs Containing DNA Encoding For the Expression of Either IL-12 or IL-15 In HIV Infected Individuals: PennVax B
A Phase I Study of Autologous T-Cells Genetically Modified by Zinc Finger Nucleases SB-728 for Reduced CCR5 Expression in HIV-Infected Patients with Detectable Plasma HIV RNA who have Developed Resistance to Highly Active Anti-Retroviral Therapy (HAART):Sangamo
Pending Trials:
If you have any questions regarding these studies, Please call 215-349-8092
updated 2/10/09
About Penn Medicine Contact Us Site Map Privacy Statement Legal Disclaimer Terms of Use
Penn Medicine , Philadelphia, PA 1-800-789-PENN © 2009, The Trustees of the University of Pennsylvania